DXCM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
CEO
Kevin Sayer
Employees
5500
Headquarters

6340 Sequence Dr
San Diego, California 92121-4356
Phone: 18582000200
www.dexcom.com

News

Dexcom''s EVP chief HR officer sells $49k worth of stock
Jun 11, 2024 22:42pm

https://www.investing.com/news/company-news/dexcoms-evp-chief-hr-officer-sells-49k-worth-of-stock-93CH-3480403


Source:Investing.com
Dexcom CFO unloads $85.7k in company stock
Jun 11, 2024 22:42pm

https://www.investing.com/news/company-news/dexcom-cfo-unloads-857k-in-company-stock-93CH-3480402


Source:Investing.com
Apple Watch Now Directly Syncs With Dexcom''s G7 Glucose Monitor
Jun 10, 2024 03:07am

Dexcom Inc. (NASDAQ: DXCM ), a leading glucose monitor manufacturer , has enabled direct Apple Inc.’s (NASDAQ: AAPL ) Watch connectivity for its G7 model in the United States. What Happened : The new feature allows G7 users to access real-time glucose data on their Apple Watch through Dexcom’s new app, without needing to sync with an iPhone . Bloomberg columnist Mark Gurman revealed the information in his latest installment of the weekly “Power On” newsletter. This update is particularly beneficial for Apple Watch users who prefer to leave their phones behind occasionally. Subscribe to the Benzinga Tech Trends newsletter to get all the latest tech developments delivered to your inbox. As of 2022, approximately 24.4 million people in the U.S. were diagnosed with diabetes, … Full story available on Benzinga.com


Source:Benzinga
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
Jun 05, 2024 10:00am

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch* in the United States. Dexcom G7 is the first and only CGM available with Direct to Apple Watch, offering users the freedom and convenience of real-time glucose readings Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
The Dexcom G7 now lets you monitor real-time blood sugar on the Apple Watch
Jun 05, 2024 10:00am

The Dexcom G7 will be able to send real-time blood sugar readings straight to the wrist. | Image: Dexcom Starting today, Dexcom G7 continuous glucose monitor (CGM) users will be able to monitor their real-time blood sugar data straight from an Apple Watch. According to Dexcom’s press release, the Direct to Apple Watch feature was one of the most requested by users. Once paired to the Apple Watch, the G7 will use its own dedicated Bluetooth connection to send both glucose readings and personalized alerts to the wrist. Meaning, you don’t have to whip out your phone if you want to view your data, nor does your phone have to be on your person. For instance, G7 users will still be able to get real-time data while on a phone-free run / walk or if your phone is charging in a different room. Previously, the G7’s Apple Watch app allowed you to have… Continue reading…


Source:The Verge
3 Best Healthcare Stocks to Buy in June 2024, as per Analysts
Jun 05, 2024 09:21am

DexCom, Cooper Companies, and Becton, Dickinson and Company are the 3 Best Healthcare Stocks to Buy in June 2024, according to Wall Street analysts…


Source:TipRanks
DexCom, Inc.: Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
Jun 04, 2024 11:06am

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those trea…


Source:Finanz Nachrichten
Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
Jun 04, 2024 11:01am

DexCom, Inc., a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating Type 2 diabetes with basal insulin injections. The French government is the first in Europe to offer full national reimbursement for Dexcom CGM technology to those… The post Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes appeared first on Insurance News | InsuranceNewsNet .


Source:InsuranceNewsNet
Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes | DXCM Stock News
Jun 04, 2024 11:00am

France approves national reimbursement for Dexcom ONE sensor, benefiting 100,000 Type 2 diabetes patients. Learn how this can improve diabetes management.


Source:Stock Titan
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
Jun 03, 2024 20:05pm

Nova Scotia becomes the latest province and territory to offer access to simple and easy-to-use diabetes management solutions, helping Canadians living with diabetes take control of their health BURNABY, British Columbia — Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova […]


Source:Financial Post